Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

CHMP4B Inhibitors

CHMP4B (Charged Multivesicular Body Protein 4B) is an essential component of the endosomal sorting complex required for transport (ESCRT-III), which plays a pivotal role in the late stages of cytokinesis, autophagy, and the formation of multivesicular bodies (MVBs). This protein is integral to the machinery that mediates the sorting of ubiquitinated membrane proteins into the lumen of the MVB, a crucial step in the degradation pathway of cellular components. CHMP4B's function is critical for the maintenance of cellular homeostasis, as it facilitates the proper segregation and distribution of cellular contents during division, and ensures the efficient turnover of membrane proteins and signaling receptors. The ESCRT-III complex, with CHMP4B as a core component, is also instrumental in the abscission phase of cytokinesis, where it helps in the final separation of daughter cells.

The inhibition of CHMP4B involves disrupting its ability to participate in the ESCRT-III complex formation or function, effectively hindering its role in membrane remodeling, MVB formation, and cytokinesis. This can be achieved through various molecular mechanisms, such as the overexpression of dominant-negative mutants that can bind to but not promote the assembly of ESCRT-III, thereby blocking the recruitment or stabilization of the complex at the membrane sites requiring remodeling. Another approach involves the use of small molecules or peptides that specifically disrupt the interactions between CHMP4B and its binding partners, hindering the proper assembly or function of the ESCRT-III complex. Additionally, the targeted degradation of CHMP4B through the use of siRNA or shRNA can diminish its levels within the cell, thereby reducing its availability for ESCRT-III complex assembly. These mechanisms of inhibition directly impact the cellular processes dependent on CHMP4B, such as the efficient turnover of cell surface receptors, the progression of cytokinesis, and the execution of autophagy, highlighting the importance of CHMP4B in cellular dynamics and homeostasis.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Spautin-1

1262888-28-7sc-507306
10 mg
$165.00
(0)

A known inhibitor of Vps34, a class III PI3K. By inhibiting Vps34, Spautin-1 could disrupt the formation of endosomes, potentially affecting CHMP4B's function in the ESCRT pathway.

Autophagy Inhibitor, 3-MA

5142-23-4sc-205596
sc-205596A
50 mg
500 mg
$56.00
$256.00
113
(3)

Inhibits class III PI3Ks, including Vps34. This inhibition could indirectly affect the endosomal sorting processes in which CHMP4B is involved.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

A broad PI3K inhibitor that could indirectly affect CHMP4B by disrupting PI3K-dependent endosomal trafficking processes.

SAR405

1523406-39-4sc-507416
1 mg
$125.00
(0)

A specific inhibitor of Vps34. By targeting Vps34, SAR405 could potentially impair endosomal formation and trafficking, indirectly inhibiting CHMP4B activity.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$87.00
44
(2)

Inhibits dynamin, a GTPase important for vesicle scission. This inhibition could affect endosomal trafficking, indirectly influencing CHMP4B's role in the ESCRT pathway.

Dynamin Inhibitor II

1119-97-7sc-203931
sc-203931A
sc-203931B
sc-203931C
5 g
250 g
500 g
1 kg
$46.00
$82.00
$122.00
$194.00
(1)

Dynamin Inhibitor II, also called MiTMAB, could indirectly inhibit CHMP4B's function in endosomal sorting.

YM201636

371942-69-7sc-204193
5 mg
$213.00
6
(1)

Inhibits PIKfyve, a kinase involved in endosome dynamics. This inhibition might impact CHMP4B's function in endosomal sorting and trafficking.

Apilimod

541550-19-0sc-480051
sc-480051A
100 mg
1 g
$420.00
$2600.00
5
(0)

A PIKfyve inhibitor. It could indirectly affect CHMP4B by altering endosome formation and trafficking.

Vacuolin-1

351986-85-1sc-216045
10 mg
$260.00
29
(2)

Increases the size of lysosomes and late endosomes. By altering endosomal dynamics, Vacuolin-1 might indirectly affect CHMP4B's role in the ESCRT pathway.

U 18666A

3039-71-2sc-203306
sc-203306A
10 mg
50 mg
$140.00
$500.00
2
(1)

Inhibits cholesterol trafficking, affecting endosomal and lysosomal pathways. This could potentially impact CHMP4B function in endosomal sorting.